Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

44.69
Delayed Data
As of Feb 17
 +0.49 / +1.11%
Today’s Change
36.76
Today|||52-Week Range
45.79
+16.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues21.8B20.2B20.4B20.9B
 
 
 
 
 
Cost of Goods Sold9.1B8.2B8.0B9.0B
 
 
 
 
 
Depreciation And Amortization1.7B1.5B1.5B--
 
 
 
 
 
Operating ExpensesGross Income11.0B10.5B11.0B11.8B
 
 
 
 
 
General Expenses8.3B7.7B8.0B8.1B
 
 
 
 
 
Other Operating Expenses0.000.000.00550.0M
 
 
Research And Development1.5B1.3B1.4B1.4B
 
 
 
 
 
Total Operating Expenses19.2B17.5B17.5B17.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.7B2.8B2.9B3.2B
 
 
 
 
 
Extraordinary Credit0.000.0079.0M--
 
 
Extraordinary Charge-82.0M-182.0M-206.0M--
 
 
 
 
Interest Expense On Debt76.0M177.0M193.0M332.0M
 
 
 
 
 
Other Expenses-69.0M35.0M434.0M-1.4B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.5B2.5B3.2B1.4B
 
 
 
 
 
Income Taxes-138.0M-797.0M-577.0M-350.0M
 
 
 
 
 
Discontinued Operations193.0M563.0M65.0M321.0M
 
 
 
 
 
Extraordinary Items0.000.001.8B16.0M
 
 
 
Net Income2.6B2.3B2.7B1.4B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6B1.5B1.5B--
 
 
 
 
Shares To Calculate EPS Diluted1.6B1.5B1.5B1.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.62$1.49$2.92$0.94
 
 
 
 
 
EPS Diluted$1.63$1.49$1.76$0.93